Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Head & Neck 1Gynecologic 1Gastrointestinal 1Endocrine 1Dermatologic 1CNS 1

Conditions

Neoplasms 5Multiple Myeloma 3Hematologic Neoplasms 3Thyroid Cancer, Papillary 2Neoplasms by Site 2Neoplasms by Histologic Type 2Melanoma 2Lymphoma, Non-Hodgkin 2Erdheim-Chester Disease 2Carcinoma, Non-Small-Cell Lung 2Xanthogranuloma, Juvenile 1Thyroid Carcinoma, Anaplastic 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Lymphoproliferative Disorders 1Laryngeal Neoplasms 1Histiocytosis, Sinus 1Histiocytosis, Langerhans-Cell 1Histiocytic Sarcoma 1Histiocytic Disorders, Malignant 1Glioma 1Colorectal Neoplasms 1Adenocarcinoma, Follicular 1

Interventions

trametinib 3dabrafenib 3zimberelimab 1sacituzumab govitecan 1pembrolizumab 1lenvatinib 1cobimetinib 1cemiplimab 1Vemurafenib 1Radiotherapy, Intensity-Modulated 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Thyroid Carcinoma, Anaplastic × cobimetinib × Clear all
NCT05768178 2025-11-24

DETERMINE

Cancer Research UK

Phase 2/3 Recruiting
30 enrolled
CNSDermatologicEndocrineGastrointestinalGynecologicHead & NeckMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Glioma, Laryngeal Neoplasms, Melanoma, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡